1 / 15

Coevolution of Epidemics, Social Networks, and Individual Behavior: A Case Study

Coevolution of Epidemics, Social Networks, and Individual Behavior: A Case Study. Jiangzhuo Chen. Joint work with Achla Marathe, and Madhav Marathe. NDSSL Technical Report 10-042. 2010 International Conference on Social Computing, Behavioral Modeling, and Prediction (SBP10)

millie
Télécharger la présentation

Coevolution of Epidemics, Social Networks, and Individual Behavior: A Case Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coevolution of Epidemics, Social Networks, and Individual Behavior: A Case Study Jiangzhuo Chen Joint work with Achla Marathe, and Madhav Marathe NDSSL Technical Report 10-042 2010 International Conference on Social Computing, Behavioral Modeling, and Prediction (SBP10) March 31st, 2010 Network Dynamics & Simulation Science Laboratory

  2. Our group members (NDSSL) Work funded in part by NIGMS, NIH MIDAS program, CDC, Center of Excellence in Medical Informatics, DTRA CNIMS, NSF, NeTs, NECO and OCI (Peta-apps) program, VT Foundation.

  3. Talk Outline • Motivation for the case study. • Major contributions. • Background: • propagation of infectious disease on social contact networks; • intervention measures. • Simulation results.

  4. Co-evolution of Behavior, Epidemics and Social Networks Policy questions: • Is there an optimum AV allocation strategy between the market-based availability and public distribution via clinics that minimizes the attack rate and recovers the cost of AV through markets? • Does “contextual behavioral adaptation” by individuals help in controlling the epidemic?

  5. Our Contributions We have developed a methodology and an associated modeling environment to study the co-evolution of individual behavior, disease dynamics and social networks.

  6. Our Contributions (cont.) We find that there is an optimal AV allocation strategy between the market and clinics that minimizes the attack rate and recovers the cost of AV through markets. We find that markets are inherently unfair in their allocation scheme but price regulations and other incentives can control this. The market based system combined with behavioral adaptation reduces the epidemic peak as well as delays it.

  7. Disease Spread in a Social Network • Within-host disease model: SEIR • State transitions are probabilistic and timed. • Between-host disease model: transmission occurs along edges of a social contact network • People + Locations => Contacts. • Transmissions are probabilistic.

  8. Interventions • Pharmaceutical interventions: vaccination or antiviral changes an individual’s role in the transmission chain • Lower susceptibility or infectiousness • Non-pharmaceutical interventions: social distancing measures change people activities and hence the social network • Generic social distancing, school closure, isolation, etc.

  9. Interventions: Multiple Models • Infection reporting/diagnosing model: infected people show symptom with a prob.; symptomatic people are diagnosed with a prob. • Antiviral distribution models: • Public sector distribution: targeted to diagnosed people, free. • Market distribution: mostly prophylaxis, not free. • Behavioral models for self-interventions: • Household isolation: when one member is diagnosed. • Household AV demand: function of local variables (budget) as well as global variables (price, disease prevalence).

  10. Case Study: Simulation Setup New River Valley population: 150K Total 15K AV supply allocated between clinics and market from all-to-clinic to all-to-market. 20 index cases are randomly picked. 45% attack rate without any intervention. The price of the AV kit can vary between $50-$150. Total household budget for the AV is 1% of the income.

  11. Experiment Results • Attack rate reaches minimum at 40% clinic allocation. • Application of clinic allocation is upper bounded by attack rate. No need to allocate more to clinics. • Extra AV can go to markets. Revenue covers cost.

  12. Effect of Prevalence, Social Distancing and Individual Behavior • Dependence of demand on disease prevalence helps to delay the peak of the epidemic by about 30 days. • Isolation is able to reduce the peak infection by 30%. • A combination of market, public distribution and contextual behavioral adaptation is indeed likely to be more “effective” in reaching the masses and controlling the epidemic.

  13. Fairness: Who Buys and Who Doesn’t? • Only top 30 percentile income households are able to buy AV through the market when demand is sensitive to prevalence. • Poorer households do not buy because early in the epidemic the prevalence is low; later in the epidemic when the prevalence increases, the price increases making it unaffordable for the poorer people.

  14. Fairness: Impact of Demand Sensitivity • Suppose demand is independent of prevalence: each household has positive demand with a fixed probability every day, only subject to budget constraint. • AV price rises gradually. More people are able to purchase it.

  15. Conclusion We have developed a system that can study the co-evolution of individual behavior, disease dynamics and social networks. It can study economic and social effect of an epidemic. There exists an optimal strategy for allocating antiviral between the market and clinics to minimize the attack rate and to recover cost of antiviral through the market. The market based system combined with behavioral adaptation lowers and delays the epidemic peak.

More Related